Cailian Liu Selected Research

Cailian Liu Research Topics

Disease

23	Neoplasms (Cancer) 01/2024 - 05/2006
11	Melanoma (Melanoma, Malignant) 01/2024 - 05/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2018
3	Experimental Melanoma 10/2021 - 05/2006
2	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2018
1	Inflammation (Inflammations) 01/2024
1	Ascites 12/2021
1	Pleural Effusion (Pleural Effusions) 12/2021
1	Disease Progression 10/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2018
1	Infections 12/2012
1	Lymphopenia (Lymphocytopenia) 10/2012
1	Fibrosarcoma 04/2009
1	Herpes Simplex 04/2008

Drug/Important Bio-Agent (IBA)

7	Immune Checkpoint InhibitorsIBA 01/2023 - 12/2014
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 05/2006
4	VaccinesIBA 01/2024 - 05/2006
4	AntigensIBA 01/2023 - 04/2008
4	AntibodiesIBA 01/2019 - 12/2014
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 04/2008
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2021 - 04/2009
3	GlucocorticoidsIBA 10/2021 - 04/2009
3	DNA (Deoxyribonucleic Acid)IBA 04/2008 - 05/2006
2	eprenetapoptIBA 01/2024 - 01/2022
2	Immunomodulating AgentsIBA 01/2024 - 06/2018
2	PhosphatidylserinesIBA 12/2021 - 12/2021
2	IpilimumabIBA 01/2015 - 12/2014
2	Monoclonal AntibodiesIBA 05/2010 - 04/2009
2	EpitopesIBA 04/2009 - 05/2006
2	Monophenol Monooxygenase (Tyrosinase)IBA 04/2009 - 05/2006
2	AutoantigensIBA 04/2009 - 05/2006
2	Peptides (Polypeptides)IBA 04/2009 - 05/2006
1	InterferonsIBA 01/2024
1	Melanoma-Specific AntigensIBA 01/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2023
1	pembrolizumabIBA 01/2022
1	Alkylating AgentsIBA 10/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021
1	EnzymesIBA 11/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2020
1	Tryptophan (L-Tryptophan)FDA Link 11/2020
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 11/2020
1	Programmed Cell Death 1 ReceptorIBA 11/2016
1	B7-H1 AntigenIBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2015
1	tremelimumabIBA 12/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2014
1	raf KinasesIBA 04/2014
1	VemurafenibIBA 04/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013
1	Transcription Factors (Transcription Factor)IBA 11/2013
1	CytokinesIBA 10/2012
1	Immunoglobulin G (IgG)IBA 05/2010
1	Pseudomonas aeruginosa Exotoxin AIBA 04/2008
1	OMPA outer membrane proteinsIBA 04/2008
1	dopachrome isomeraseIBA 05/2006
1	LigandsIBA 05/2006
1	tyrosinase-related protein-1IBA 05/2006
1	Differentiation AntigensIBA 05/2006
1	DNA VaccinesIBA 05/2006

Therapy/Procedure

10	Immunotherapy 01/2024 - 04/2008
6	Therapeutics 01/2023 - 01/2018
3	Ligation 11/2013 - 05/2006
1	Radiotherapy 12/2021
1	Hematopoietic Stem Cell Transplantation 12/2012
1	Drug Therapy (Chemotherapy) 10/2012